A | B |
pre-b | µ ; pre-b rcptr |
pre-b | recomb Hc VDJ; µ mRNA |
Immature-B | IgM; recmb Hc: κ γ (VJ) |
Immature-B | negative selection |
Mature-b | alternative splicing |
TH1 | macrophage activation |
TH2 | eosinophils/mast cells |
CTLS | cytotoxicity/macrophage activation |
NK | cytotoxicity/macrophage activation |
ADCMC | NK cells |
NKcell | antibody depdt cell med. cytotoxicity |
FcRS | allow overlap btwn humoral and innate |
CD40 | CD54 |
TH1 | IL-18 |
TH2 | dev |
TH1 | IFN-γ; tbet |
TH1 | stat 4→IFN-γ ↑ th1 |
IFN-γ | activates macrophages |
activate-neutrophils | lymphotoxin & tnf |
T-cell-amplification | ↑ B7 xprsn costims on MCH (B7) |
CRC3 | antigen-binding, diversity |
junctional diversity | +/- nucltds @ V+D or D+J |
Rag 1/Rag 2 | cleaves exons, forms hairpin |
N nucleotides | non-template encoded |
P nucleotides | ARTEMIS/complementary/VDJ |
fetal liver derived stem cells | B-1 B-cells |
BONE MARROW DERIVED HSC | FOLLICULAR B-CELLS |
CLP | COMMON LYMPHIOD PROGENITOR |
NEGATIVE SELECTION | STRONG SELF ANTIGEN BINDING |
POSITIVE SELECTION | WEAK SELF ANTIGEN BINDING |
TdT | mediates nucleotide addition at junctions |
PCR | detect tumor cells in blod or tissue |
ARTEMIS | CLEAVES GERMLINE ENDS, ASYMETRICALLY |
TdT | NON-TEMPLATE ADDITION OF NCLTDS |
EBF-E2A-Pax5 encode | Rag1 and 2 |
EBF-EZA-Pax 5 | B-cell committment |
Notch-1, GATA 3 | T-cell committment |
Pro-B to Pre-B | IgM rearrangement |
IgA deficiency | Giardia, TACI mutation |
ICAM | LFA-1 |
1-3 HOURS | C-fos |
4-24HRS | CD40 LIGAND |
3 HRS-4 DAYS | IL-2 RECEPTOR |
6 HRS-2 DAYS | IL-2 |
6 HRS-4 DAYS | DNA SYNTHESIS |
4DAYS- 1-2WKS | VLA-4,-5,-6 |
DC1 USES | IL-12 |
DC2 USES | IFN-ALPHA, -BETA |
PRE-DC1 | GM-CSF + IL-4 + CD40L |
DC1 MAKES | IFN-GAMMA |
DC2 MAKES | IFN-GAMMA, IL-10 |
CD28 | B-7 |
CD45 | IMMUNE SYNAPSE |
c-KIT | PRE-PRO T-CELL |
UNIVERSAL SURVIVAL SURFACE SIGNAL | c-KIT |
UNIVERSAL T-CELL JUICE | INTERLEUKIN-2 |
MEDUALLARY CORTICAL JUNCTION | NEGATIVE SELECTION |
SMP/SMP1 | EXIT GERMINAL CENTER |
DE-ADENINE DEAMINASE | TH1 TH2 MIGRATION? |
INCREASE IN IL-7 | CHANGE IN M/E RATIO |